Results for breakpoints translation from English to Maltese

breakpoints
punti kruċjali

eucast breakpoints
breakpoints tal-eucast

mic breakpoints (mg/l)
breakpoints tal-mic (mg/l)

breakpoints eucast breakpoints
punti mill- mic eucast

the eucast mic breakpoints are as follows:
il- breakpoints ta 'l- nccls mic huma kif ġej:

breakpoints relevant to the indications are acceptable.
breakpoints relevanti għall- indikazzjonijiet huma aċċettabbli.

ecoff values do not equate to clinical breakpoints.
il- valuri ecoff ma jwasslux għal breakpoints kliniċi.

eucast clinical mic breakpoints for moxifloxacin (31.01.2006):
punti kritiċi ta ’ mic kliniċi eucast għal moxifloxacin (31. 01. 2006):

the recommended mic breakpoints for telithromycin, separating susceptible organisms from i
il- livelli ta ’ breakpoints ta` mic rakkomandati għal telithromycin, li jaqsmu l- mikrobi suxxettibli minn dawk b`suxxettibilità intermedja, u mikrobi b`suxxettibiltà intermedja minn dawk reżistenti, na

2 eucast has not determined non-species related breakpoints for anidulafungin
2 eucast ma ddeterminax il-punti kritiċi relatati man-nonspeċi għall- anidulafungin

4 eucast has not determined non-species related breakpoints for voriconazole.
4 eucast ma ddeterminatx breakpoints għal voriconazole li m’humiex relatati ma’ l-ispeċi.

clinical breakpoints s ≤ 0.25 mg/l; r > 0.25 mg/l
punti ta’ riferiment kliniku s ≤ 0.25 mg/l; r > 0.25 mg/l

there are currently insufficient data to set clinical breakpoints for other aspergillus species.
bħalissa m‟hemmx biżżejjed dejta biex jiġu stabbiliti l-valuri kritiċi għal speċijiet oħrajn ta‟ aspergillus.

the prescribers are informed that local mic breakpoints, if available, should be consulted.
min jagħti riċetta għal dan il- prodott huwa infurmat li għandha ssir referenza għal breakpoints lokali ta 'l- mic, jekk jeżistu.

breakpoints separate susceptible strains from strains with intermediate susceptibility and the latter from resistant strains:
punti kritiċi jisseparaw razez suxxettibli minn razez b’ suxxettibilità intermedja u dawn ta ’ l- aħħar minn razez reżistenti:

s ≤ 1mg/ l and r > 1 mg/ l • non species related breakpoints:
s ≤ 1mg/ l u r > 1 mg/ l • breakpoints mhux relatati ma ’ l- ispeċi:

the following tildipirosin breakpoints have been established for bovine respiratory disease (according to clsi guideline vet02 a3):
tildiprosin breakpoints ġew stabbiliti għall-mard respiratorju tal-ħnieżer (skond is-clsi gwidi linja vet02 a3) kif ġej:

the european committee on antimicrobial susceptibility testing (eucast) breakpoints for susceptibility testing are presented below.
il-breakpoints tal-kumitat ewropew dwar l-ittestjar tas-suxxettibilità antimikrobika (eucast) għall-ittestjar tas-suxxettibilità huma ppreżentati hawn taħt.

the recommended european committee for antimicrobial susceptibility testing (eucast) mic clinical breakpoints are presented below:
il-breakpoints kliniċi ta` mic rakkomandati mill-kumitat ewropew għall-itestjar ta’ suxxettibilità kontra l-mikrobu (eucast) huma murija hawn taħt:

minimum inhibitory concentration breakpoints established by the european committee on antimicrobial susceptibility testing (eucast) are as follows:
il-breakpoints tal-konċentrazzjoni inibitorja minima stabbiliti mill-kumitat ewropew dwar ittestjar għas-suxxettibbiltà antimikrobjali (eucast - european committee on antimicrobial susceptibility testing) huma kif ġej: